Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial

Jean-Michel MolinaBirgit GrundFred GordinIan WilliamsNoluthando MwelaseE et al2023-04-132023-04-13ISI2352-3018https://hdl.handle.net/10539/35048Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial